PATENT CLAIM ANALYSIS

Application Number: 15745552
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "047000"]

Abstract:
A pharmaceutical composition containing nicotinamide adenine dinucleotide (NAD) as an active ingredient for preventing and treating obesity or impaired glucose tolerance, a food composition, and a method for preventing and treating obesity or impaired glucose tolerance using the same is disclosed. The NAD remedies an abnormal food intake pattern of an obese animal model induced by the intake of a high-fat diet and increases mobility, thereby exhibiting an effect of suppressing the weight increase due to the high-calorie intake and also showing an effect of improving glucose tolerance. In addition, it was verified that the NAD is capable of maintaining the above effects with even a much smaller quantity than an NAD precursor known in the prior art. Therefore, the composition containing NAD can be favorably used as a pharmaceutical composition or a food composition capable of effectively preventing and treating obesity or impaired glucose tolerance.

Claim (Index 3):
The method of  claim 1 , wherein the NAD or the pharmaceutically acceptable salt thereof increases a physical activity of the obese patient.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 86.0
- Lexical Diversity: 1.8046
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14855293', '15783845', '11542790', '14434573', '15644247']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7805807636273414
- 35 USC 102 Novelty (BERT): 0.5290979734212699
- Combined Prediction Score: 0.7554324846067343
- Mean Citation Score: 306.839204
- Max Citation Score: 338.21616
- Similarity Product: 217.9222017963696

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test